Zeus Scientific

ZEUS Scientific is an established, privately-held diagnostics company founded in 1987 and headquartered in Lincoln, USA. It has built a robust portfolio centered on autoimmune and infectious disease diagnostics, leveraging three core technology platforms: ELISA, multiplex bead arrays, and immunofluorescence. The company operates a dual business model, selling its own branded test systems and reagents directly to clinical labs while also offering extensive custom development and OEM manufacturing services to other diagnostics firms. Backed by experienced technical leadership and a focus on workflow efficiency, ZEUS is positioned in the growing global autoimmune diagnostics market, though it faces competition from larger, diversified players.

Three core diagnostic platforms: 1) ZEUS ELISA for quantitative/semi-quantitative antibody detection; 2) AtheNA Multi-Lyte multiplex bead-based immunoassay system for simultaneous multi-analyte detection; 3) ZEUS IFA (Indirect Immunofluorescence Assay) supported by the automated ZEUS dIFine 30 System for slide processing, digital imaging, and pattern analysis.

ZEUS Scientific competes in the autoimmune and infectious disease diagnostics market against large, multinational IVD companies like Werfen (Inova), Thermo Fisher, Bio-Rad, and Siemens Healthineers. It differentiates through deep specialization in immunology, a complete automated IFA solution (dIFine 30), a flexible OEM/CDMO business model, and a focus on US-based manufacturing and customer support.